Aim:

Trends in Pharmaceutical Biotechnology (TPB) aims to advance and disseminate high-quality research that bridges innovation and application in the rapidly evolving field of pharmaceutical biotechnology.The journal provides a platform for original research articles, comprehensive reviews, and short communications that explore novel biotechnological approaches for the discovery, development, and delivery of modern therapeutics. By fostering collaboration between academia, research institutions, and industry, TPB seeks to accelerate the translation of scientific discoveries into effective biopharmaceutical products that improve patient care and public health.

Scope:

TPB covers a wide spectrum of topics within pharmaceutical biotechnology, including but not limited to:

 •⁠ ⁠Biopharmaceuticals, biosimilars, and monoclonal antibodies.
•⁠  ⁠Gene and cell therapies.
•⁠  ⁠mRNA and nucleic acid–based technologies.
•⁠  ⁠CRISPR and other gene-editing tools in drug discovery.
•⁠  ⁠Nanotechnology and targeted drug delivery systems.
•⁠  ⁠Immunotherapy and regenerative medicine.
•⁠  ⁠Drug repurposing and personalized medicine.
•⁠  ⁠Bioprocessing, formulation, and analytical biotechnology.

The journal welcomes interdisciplinary studies and emerging trends that contribute to innovation, sustainability, and translational impact in global pharmaceutical biotechnology.